Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.36 | N/A |
| PEG Ratio (TTM) | -4.93 | N/A |
| P/S Ratio (TTM) | 2.98 | N/A |
| P/B Ratio (TTM) | 1.28 | N/A |
| P/FCF Ratio (TTM) | 11.79 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.95 | N/A |
| Price to 5YR AVG FCF Ratio | 15.67 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.24% | N/A |
| ROE (TTM) | 9.92% | N/A |
| Net Profit Margin (TTM) | 22.42% | N/A |
| ROIC 5YR AVG | 15.98% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1.19% | 15.37% | 17.69% |
| Revenue | 1.86% | 4.05% | 9.81% |
| Net Income | -0.96% | 15.56% | 24.42% |
| Cash Flow | 14.29% | 584.51% | 350.18% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.04 | N/A |
| Interest Coverage (TTM) | 1.04 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.44 | N/A |
| LTL to 5YR AVG FCF | 3.76 | N/A |
| Shares Outstanding Growth 5YR AVG | 4.50% | N/A |